Drug-Drug interactions between COVID-19 treatments and antipsychotics drugs: integrated evidence from 4 databases and a systematic review

2020-06-08 pharmacology and therapeutics Title + abstract only

Show abstract

RelevanceManagement of symptoms like anxiety, delirium and agitation cannot be neglected in COVID-19 patients. Antipsychotics are usually used for the pharmacological management of delirium, and confusion and behavioral disturbances. The selection of concomitant COVID-19 medications and antipsychotics should be evidence-based and closely monitored ObjectiveTo systematically review evidence-based available on drug-drug interactions between COVID-19 treatments and antipsychotics. Evidence Review...

Drug-Drug interactions between COVID-19 treatments and antipsychotics drugs: integrated evidence from 4 databases and a systematic review

Predicted journal destinations